3.23
1.25%
0.04
전일 마감가:
$3.19
열려 있는:
$3.15
하루 거래량:
5.01M
Relative Volume:
0.72
시가총액:
$1.62B
수익:
$1.70B
순이익/손실:
$-123.70M
주가수익비율:
-5.9168
EPS:
-0.5459
순현금흐름:
$-178.21M
1주 성능:
+3.86%
1개월 성능:
-3.58%
6개월 성능:
+213.59%
1년 성능:
+229.59%
Clover Health Investments Corp Stock (CLOV) Company Profile
명칭
Clover Health Investments Corp
전화
(201) 432-2133
주소
3401 MALLORY LANE, SUITE 210, FRANKLIN
CLOV을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
CLOV
Clover Health Investments Corp
|
3.23 | 1.62B | 1.70B | -123.70M | -178.21M | -0.2663 |
UNH
Unitedhealth Group Inc
|
500.13 | 460.26B | 389.07B | 14.32B | 13.10B | 15.35 |
ELV
Elevance Health Inc
|
365.96 | 84.87B | 174.02B | 6.42B | 871.00M | 27.43 |
CI
Cigna Group
|
276.92 | 77.03B | 229.75B | 3.04B | 5.18B | 10.60 |
CVS
Cvs Health Corp
|
44.36 | 55.82B | 368.91B | 5.02B | 1.69B | 3.94 |
CNC
Centene Corp
|
59.58 | 30.08B | 161.73B | 3.07B | 245.00M | 5.76 |
Clover Health Investments Corp Stock (CLOV) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2024-12-17 | 개시 | Craig Hallum | Buy |
2024-10-07 | 개시 | UBS | Neutral |
2022-02-02 | 개시 | Canaccord Genuity | Buy |
2022-02-02 | 업그레이드 | Cowen | Underperform → Market Perform |
2022-01-19 | 개시 | SVB Leerink | Mkt Perform |
2022-01-10 | 재개 | Citigroup | Neutral |
2022-01-07 | 다운그레이드 | Credit Suisse | Neutral → Underperform |
2021-09-10 | 개시 | Cowen | Underperform |
2021-09-02 | 재개 | Citigroup | Neutral |
2021-07-12 | 다운그레이드 | JP Morgan | Neutral → Underweight |
2021-06-10 | 다운그레이드 | BofA Securities | Neutral → Underperform |
2021-05-17 | 다운그레이드 | BofA Securities | Buy → Neutral |
2021-03-09 | 개시 | Credit Suisse | Neutral |
2021-02-02 | 개시 | Citigroup | Buy |
2021-02-01 | 개시 | JP Morgan | Neutral |
모두보기
Clover Health Investments Corp 주식(CLOV)의 최신 뉴스
Recent Earnings Disappointment Could Be An Ideal Buying Opportunity For Clover Health - Seeking Alpha
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases New Shares in Clover Health Investments, Corp. (NASDAQ:CLOV) - MarketBeat
Clover Health CEO to Present at J.P. Morgan's Prestigious Healthcare Conference in 2025 - StockTitan
Clover Health to Participate in Upcoming 43rd Annual J.P. Morgan Healthcare Conference - Yahoo Finance
Clover Health draws new Buy at Craig-Hallum despite sharp YTD gains - MSN
Clover Health stock draws Buy at Craig-Hallum (CLOV:NASDAQ) - Seeking Alpha
Clover Health Investments (NASDAQ:CLOV) Trading Up 3.5%What's Next? - MarketBeat
Craig Hallum Initiates Coverage on Clover Health Investments (NASDAQ:CLOV) - MarketBeat
Clover Health Investments, Corp. (NASDAQ:CLOV) Sees Large Decline in Short Interest - MarketBeat
Janus Henderson Group PLC Takes Position in Clover Health Investments, Corp. (NASDAQ:CLOV) - MarketBeat
4-star Upgrade To Power Clover Health’s (CLOV) Comeback - Insider Monkey
Clover Health Investments, Corp. (NASDAQ:CLOV) Shares Sold by Quadrature Capital Ltd - MarketBeat
Point72 Asset Management L.P. Acquires Shares of 260,650 Clover Health Investments, Corp. (NASDAQ:CLOV) - MarketBeat
Clover Health: Balancing Innovation And Challenges (NASDAQ:CLOV) - Seeking Alpha
(CLOV)Analyzing Clover Health Investments's Short Interest - Benzinga
Clover Health Set To Join Russell 3000® Index - Barchart
Here's Why Clover Health Investments (CLOV) Could be Great Choice for a Bottom Fisher - MSN
The Zacks Analyst Blog Highlights Inspire Medical, Omnicell, Talkspace, Butterfly Network and Clover Health - Barchart
5 Medical Info System Stocks to Buy for a Stable Portfolio in 2025 - MSN
CLOV (Clover Health Investments) 3-Year FCF Growth Rate : 6.40% (As of Sep. 2024) - GuruFocus.com
Has CareDx (CDNA) Outpaced Other Medical Stocks This Year? - Yahoo Finance
Bears are Losing Control Over Clover Health Investments (CLOV), Here's Why It's a 'Buy' Now - MSN
Clover Health Investments (NASDAQ:CLOV) Stock Quotes, Forecast and News Summary - Benzinga
CLOV (Clover Health Investments) 3-Year EPS without NRI Gro - GuruFocus.com
CLOV (Clover Health Investments) Future 3-5Y Total Revenue Growth Rate : N/A (As of Nov. 26, 2024) - GuruFocus.com
CLOV (Clover Health Investments) Other Current Liabilities : $50 Mil (As of Sep. 2024) - GuruFocus.com
Connor Clark & Lunn Investment Management Ltd. Raises Holdings in Clover Health Investments, Corp. (NASDAQ:CLOV) - MarketBeat
CLOV (Clover Health Investments) Forward Dividend Yield % : 0.00% (As of Nov. 25, 2024) - GuruFocus.com
PNC Financial Services Group Inc. Trims Position in Clover Health Investments, Corp. (NASDAQ:CLOV) - MarketBeat
Down -26.32% in 4 Weeks, Here's Why Clover Health Investments (CLOV) Looks Ripe for a Turnaround - MSN
Clover Health Investments, Corp. (CLOV) Reports Q3 Loss, Lags Revenue Estimates - MSN
2024's 10 Best-Performing Stocks | Investing - U.S News & World Report Money
Clover Health: Buy The Dip, Reap The Rewards - Seeking Alpha
Clover Health Investments, Corp. (NASDAQ:CLOV) Sees Significant Increase in Short Interest - MarketBeat
GSA Capital Partners LLP Reduces Stock Position in Clover Health Investments, Corp. (NASDAQ:CLOV) - MarketBeat
Down -25.82% in 4 Weeks, Here's Why Clover Health Investments (CLOV) Looks Ripe for a Turnaround - Yahoo Finance
Avant Technologies Launches AI Healthcare Venture to Transform $188B Medical Imaging Market | CLOV Stock News - StockTitan
What is Leerink Partnrs' Estimate for CLOV FY2024 Earnings? - MarketBeat
Clover Health Investments Corp. (CLOV) Quarterly 10-Q Report - Quartz
Clover Health Investments, Corp. (NASDAQ:CLOV) Q3 2024 Earnings Call Transcript - Insider Monkey
Leerink Partnrs Issues Positive Forecast for CLOV Earnings - MarketBeat
Clover Health Investments, Corp. (NASDAQ:CLOV) Just Reported Third-Quarter Earnings And Analysts Are Lifting Their Estimates - Simply Wall St
Clover Health Investments Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
Clover Health Investments Corp (CLOV) Q3 2024 Earnings Call High - GuruFocus.com
Clover Health Investments Corp (CLOV) Q3 2024 Earnings Call Highlights: Strong Financial - Yahoo Finance
Clover Health Investments (NASDAQ:CLOV) Shares Gap DownTime to Sell? - MarketBeat
CLOV Stock Declines Despite Q3 Earnings Beat, FY24 View Revised - Yahoo Finance
December 27th Options Now Available For Clover Health Investments (CLOV) - Nasdaq
Clover Health Reports Strong Financial Growth in Q3 2024 - TipRanks
Clover Health Investments Corp (CLOV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Clover Health Investments Corp 주식 (CLOV) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
Garipalli Vivek | Director |
Jun 17 '24 |
Buy |
1.14 |
877,567 |
1,000,426 |
877,567 |
Loengard Anna U | Director |
May 16 '24 |
Buy |
0.96 |
17,085 |
16,372 |
15,600 |
Loengard Anna U | Director |
May 17 '24 |
Buy |
0.93 |
10,000 |
9,300 |
10,000 |
Loengard Anna U | Director |
Mar 14 '24 |
Buy |
0.73 |
137,000 |
100,010 |
538,841 |
Loengard Anna U | Director |
Mar 14 '24 |
Buy |
0.73 |
13,625 |
9,946 |
15,125 |
자본화:
|
볼륨(24시간):